药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aprobarbital
Grazoprevir
The serum concentration of Grazoprevir can be increased when it is combined with Edoxaban.
Aprobarbital
Elbasvir
The serum concentration of Elbasvir can be increased when it is combined with Edoxaban.
Aprobarbital
Selexipag
The serum concentration of Selexipag can be increased when it is combined with Edoxaban.
Aprobarbital
Osimertinib
The serum concentration of Osimertinib can be increased when it is combined with Edoxaban.
Aprobarbital
Ombitasvir
The serum concentration of Ombitasvir can be increased when it is combined with Edoxaban.
Aprobarbital
Dasabuvir
The serum concentration of Dasabuvir can be increased when it is combined with Edoxaban.
Aprobarbital
Technetium Tc-99m sestamibi
The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Edoxaban.
Aprobarbital
Lenvatinib
The serum concentration of Lenvatinib can be increased when it is combined with Edoxaban.
Aprobarbital
Umeclidinium
The serum concentration of Umeclidinium can be increased when it is combined with Edoxaban.
Aprobarbital
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Edoxaban.
Aprobarbital
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Edoxaban.
Aprobarbital
Bendamustine
The serum concentration of Bendamustine can be increased when it is combined with Edoxaban.
Aprobarbital
Cefamandole nafate
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Cefamandole nafate.
Aprobarbital
Cepeginterferon alfa-2B
The risk or severity of bleeding can be increased when Edoxaban is combined with Cepeginterferon alfa-2B.
Aprobarbital
Peginterferon beta-1a
The risk or severity of bleeding can be increased when Edoxaban is combined with Peginterferon beta-1a.
Aprobarbital
Dinutuximab
The risk or severity of bleeding can be increased when Edoxaban is combined with Dinutuximab.
Aprobarbital
Blinatumomab
The risk or severity of bleeding can be increased when Edoxaban is combined with Blinatumomab.
Aprobarbital
Tedizolid phosphate
The risk or severity of bleeding can be increased when Edoxaban is combined with Tedizolid phosphate.
Aprobarbital
Tofacitinib
The risk or severity of bleeding can be increased when Edoxaban is combined with Tofacitinib.
Aprobarbital
Eribulin
The risk or severity of bleeding can be increased when Edoxaban is combined with Eribulin.